ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 515.00
-10.00 (-1.90%)
Sep 25, 2026, 4:59 PM CET
ChemoMetec Balance Sheet
Financials in millions DKK. Fiscal year is July - June.
Millions DKK. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 290.17 | 341.85 | 296.15 | 316.57 | 209.03 |
Short-Term Investments | 3.39 | - | - | - | - |
Cash & Short-Term Investments | 293.56 | 341.85 | 296.15 | 316.57 | 209.03 |
Cash Growth | -14.13% | 15.43% | -6.45% | 51.45% | 39.25% |
Accounts Receivable | 89.6 | 79.62 | 62.26 | 54.83 | 65.87 |
Other Receivables | 9.59 | 6.3 | 6.82 | 4.91 | 3.67 |
Receivables | 99.2 | 85.92 | 69.08 | 59.74 | 69.54 |
Inventory | 126.21 | 120.75 | 119.5 | 112.64 | 66.79 |
Prepaid Expenses | 5.83 | 6.06 | 5.08 | 3.71 | 7.58 |
Other Current Assets | 0 | - | - | - | - |
Total Current Assets | 524.8 | 554.58 | 489.8 | 492.66 | 352.93 |
Property, Plant & Equipment | 126.62 | 115.61 | 92.05 | 82.69 | 74.78 |
Goodwill | 7.36 | 7.35 | - | - | - |
Other Intangible Assets | 200.83 | 145.69 | 94.55 | 79.66 | 67.4 |
Long-Term Deferred Tax Assets | - | 15.05 | - | 2.65 | 5.85 |
Other Long-Term Assets | 1.28 | 1.18 | 0.28 | 0.32 | 0.3 |
Total Assets | 860.9 | 839.46 | 676.67 | 657.98 | 501.27 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 38.05 | 16.08 | 11.09 | 17.55 | 17.02 |
Accrued Expenses | 13.35 | 20.96 | 13.48 | 8.2 | 30.18 |
Current Portion of Long-Term Debt | 1.53 | 1.47 | 1.33 | 1.01 | 1.03 |
Current Portion of Leases | 1 | 1.92 | 1.85 | 2.51 | 0.91 |
Current Income Taxes Payable | 26.84 | 48.42 | 19.96 | 43.44 | 54.62 |
Current Unearned Revenue | 47.48 | 54.86 | 50.82 | 46.48 | 33.62 |
Other Current Liabilities | -0 | - | - | - | - |
Total Current Liabilities | 128.25 | 143.71 | 98.53 | 119.19 | 137.38 |
Long-Term Leases | 2.06 | 3.02 | 0.97 | 3.64 | 4.86 |
Long-Term Deferred Tax Liabilities | 1.55 | - | 8.45 | - | - |
Other Long-Term Liabilities | 3.65 | 4.68 | 3.4 | 2.1 | 1.83 |
Total Liabilities | 135.51 | 151.41 | 111.36 | 124.93 | 144.07 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 |
Retained Earnings | 733.01 | 652.99 | 547.89 | 515.62 | 339.78 |
Comprehensive Income & Other | -25.02 | 17.66 | 0.02 | 0.02 | 0.03 |
Shareholders' Equity | 725.39 | 688.05 | 565.32 | 533.04 | 357.21 |
Total Liabilities & Equity | 860.9 | 839.46 | 676.67 | 657.98 | 501.27 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 4.59 | 6.4 | 4.16 | 7.16 | 6.79 |
Net Cash (Debt) | 288.97 | 335.45 | 291.99 | 309.41 | 202.23 |
Net Cash Growth | -13.85% | 14.88% | -5.63% | 53.00% | 36.87% |
Net Cash Per Share | 16.61 | 19.28 | 16.78 | 17.78 | 11.62 |
Filing Date Shares Outstanding | 17.2 | 17.4 | 17.4 | 17.4 | 17.4 |
Total Common Shares Outstanding | 17.3 | 17.4 | 17.4 | 17.4 | 17.4 |
Working Capital | 396.56 | 410.87 | 391.27 | 373.47 | 215.56 |
Book Value Per Share | 41.94 | 39.54 | 32.48 | 30.63 | 20.53 |
Tangible Book Value | 517.2 | 535.01 | 470.77 | 453.38 | 289.81 |
Tangible Book Value Per Share | 29.90 | 30.74 | 27.05 | 26.05 | 16.65 |
Land | 76.62 | 76.62 | 72.04 | 69.36 | 58.23 |
Machinery | 91.78 | 87.99 | 72.24 | 72.16 | 76.1 |
Construction In Progress | 38.91 | 41.35 | 28.17 | 13.54 | - |